Mats Peter Nordberg

Title: Innovations of Mats Peter Nordberg

Introduction

Mats Peter Nordberg is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating hyperlipidaemia. With a total of three patents to his name, Nordberg's work has had a meaningful impact on lipid metabolism disorders.

Latest Patents

Nordberg's latest patents include innovative compounds such as benzothiazepine derivatives. These compounds are described as pharmaceutically acceptable salts, solvates, and prodrugs, which serve as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Additionally, he has developed diphenylazetidinone derivatives that act as cholesterol absorption inhibitors, also aimed at treating hyperlipidaemia. Both patents detail processes for their manufacture and pharmaceutical compositions containing these compounds.

Career Highlights

Throughout his career, Mats Peter Nordberg has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Albireo AB. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Nordberg has collaborated with notable colleagues such as Ingemar Starke and Mikael Ulf Johan Dahlstrom. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Mats Peter Nordberg's contributions to pharmaceutical innovations demonstrate his commitment to improving treatments for lipid metabolism disorders. His patents reflect a deep understanding of medicinal chemistry and a dedication to advancing healthcare solutions.